PRODRUG CONTAINING A SELF-CLEAVABLE LINKER Russian patent published in 2023 - IPC A61K47/60 A61K47/65 A61K38/17 A61K38/18 

Abstract RU 2798085 C2

FIELD: pharmaceuticals.

SUBSTANCE: invention relates to a prodrug, or a pharmaceutically acceptable salt thereof, containing a drug-linker conjugate D-L, wherein D is a nitrogen-containing polypeptide; L is a biologically inactive linker fragment L1 represented by the structural formula (I) where the dotted line demonstrates the attachment to the nitrogen of the polypeptide through the formation of an amide bond, where R1, Rla, R2, R2a, R3, R3a, X, X1, X2, X3 have the meanings given in the claims, and where L1 is substituted by 1–4 L2-Z groups, provided that the hydrogen marked with * in formula (I) cannot be substituted by a substituent; where L2 represents a single chemical bond or spacer; and Z represents a carrier group such as a linear or branched poly(ethylene glycol) with a molecular weight of 2,000 to 150,000 Da.

EFFECT: obtaining a prodrug containing a self-cleavable linker.

12 cl, 3 dwg, 52 ex

Similar patents RU2798085C2

Title Year Author Number
PRODRUG CONTAINING SELF-CLEAVABLE LINKER 2014
  • Kleeman Feliks
  • Kherzel Ulrikh
  • Kaden Silviya
  • Rau Kharald
  • Vegge Tomas
RU2676324C2
PRODRUGS CONTAINING EXENDIN CONJUGATE-LINKER 2011
  • Kleemann Feliks
  • Kherzel Ulrikh
  • Lessmann Torben
  • Rau Kharald
RU2593774C2
PRODRUGS CONTAINING INSULIN LINKER CONJUGATE 2010
  • Rau Kharal'D
  • Kleemann Feliks
  • Kherzel' Ul'Rikh
  • Kaden-Fagt Sil'Vija
  • Lessmann Torben
  • Vegge Tomas
RU2574667C2
PRODRUGS CONTAINING HYALURONIC ACID CONJUGATE, LINKER AND DOUBLE AGONIST GLP-1/GLUCAGON 2016
  • Kadereit, Dieter
  • Wagner, Michael
  • Olpp, Thomas
  • Meyer, Nino
  • Dhal, Pradeep
  • Konowicz, Paul
  • Miller, Robert
  • Stefano, James
  • Besev, Magnus
  • Bossart, Martin
  • Lorenz, Katrin
  • Haack, Torsten
  • Evers, Andreas
RU2719482C2
LONG-ACTING INSULIN COMPOSITION 2010
  • Sprogee Kennett
  • Kleemann Feliks
  • Kherzel' Ul'Rikh
  • Kaden-Fagt Sil'Vija
  • Lessmann Torben
  • Rau Kharal'D
  • Vegge Tomas
RU2556340C2
VEGF NEUTRALISING PRODRUGS FOR THE TREATMENT OF OCULAR CONDITIONS 2013
  • Rau Kharald
  • Knappe Tomas
  • Laufer Burkkhardt
  • Rajmann Romi
  • Vajsbrod Zamyuel
  • Sproge Kennett
  • Bizek Nikola
  • Shtark Zebastian
  • Fojgt Tobias
RU2673881C2
NEW PSA-BINDING AGENTS AND THEIR USE 2018
  • Benesova Martina
  • Mueller Cristina
  • Umbricht Christoph
  • Schibli Roger
  • Zhernosekov Konstantin
RU2787105C2
BIODEGRADABLE WATER-INSOLUBLE POLYETHYLENEGLYCOL-BASED HYDROGELS 2010
RU2554854C9
PEPTIDE COMPOUND CAPABLE OF BINDING WITH PSMA, METHOD FOR PRODUCTION AND USE THEREOF 2021
  • Petrov Stanislav Aleksandrovich
  • Machulkin Aleksej Eduardovich
  • Larenkov Anton Alekseevich
  • Uspenskaya Anastasiya Alekseevna
  • Nimenko Ekaterina Alekseevna
  • Zyk Nikolaj Yurevich
  • Skvortsov Dmitrij Aleksandrovich
  • Shafikov Radik Radikovich
  • Beloglazkina Elena Kimovna
  • Mazhuga Aleksandr Georgievich
RU2823164C2
CONJUGATES: THERAPEUTIC COMPOUND-FATTY ACID 1994
  • Robert Dzhordzh Vittehker
  • Veronika Dzhudit Bender
  • Vejn Dzherrard Rejlli
RU2137755C1

RU 2 798 085 C2

Authors

Kleemann, Feliks

Kherzel, Ulrikh

Kaden, Silviya

Rau, Kharald

Vegge, Tomas

Dates

2023-06-15Published

2018-12-10Filed